FDA requiring lower recommended dose for certain sleep drugs containing zolpidem to reduce risk of drowsiness.
On January 10, 2013 the U.S. Food and Drug Administration (FDA) notified the public of new information about zolpidem, a widely prescribed insomnia drug. FDA recommends that the bedtime dose be lowered because new data show that blood levels in some patients may be high enough the morning after use to impair activities that require